FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Former White House press secretary Karoline Leavitt opens up about Trump, motherhood

Pentagon sends hundreds of Army troops to Latin America for training as drug-trafficking campaign expands

Trump announces advanced weapons testing ‘super range’ in Montana

MS NOW Falsely Reports Kash Patel Is in Russia – Gets Brutally Fact-Checked Directly by the FBI

Tension erupts during House midterm debate as Lawler fact-checks New York Democrat opponent on immigration

‘Serial Killer’ Concerns Grip Michigan’s Capital as Similarities Are Noted in 5 Recent Deaths

Copper theft suspect’s desperate escape caught on bodycam video before deputies discover what he left behind

Trump torches Democrats at Arizona rally, warns they will ‘destroy our country’ ahead of midterms

Will Trump’s contempt for Zelensky force Ukraine to choose between an election and survival?

FBI Says Saudi OpenAI Employee Bugged Company to Spy on Top Executives

Federal agents seize phone of Rep. Ilhan Omar in raid tied to immigration fraud probe

DOJ threatens emergency legal action against California over suspected noncitizen voters

High School Football Coach Fired, Allegedly for Running Up Score Against Lesser Opponent

House Democrat Reveals Plan to Knock Maxine Waters Off Her Leadership Pedestal, Sparking Internal Turmoil

Fox News Poll: Cost of living concerns weigh on GOP in midterms

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”